2023 GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal J Hematol Oncol.
2023 Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Sebastian Giebel Journal Am J Hematol.
2023 Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study Group Acute Leukemia Working Party (ALWP) 1st listed author Joshua A Fein Journal Blood Adv.
2023 Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial Group Chronic Malignancies Working Party (CMWP) 1st listed author Thomas Schroeder Journal Haematologica.
2023 A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author Roni Tamari Journal Blood Adv.
2023 Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Bone Marrow Transplant.
2023 Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study Group Chronic Malignancies Working Party (CMWP) 1st listed author Nico Gagelmann Journal Eur J Haematol.
2023 The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Olivier Tournilhac Journal Bone Marrow Transplant.
2023 Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Hemasphere.
2023 Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) Group Acute Leukemia Working Party (ALWP) 1st listed author Eleni Gavriilaki Journal Bone Marrow Transplant.
2023 The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) Nursing Research Committee 1st listed author Amanda Casirati Journal Bone Marrow Transplant.
2023 Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO): a survey of EBMTcenters on behalf of the EBMT Nurses Group Group Nursing Research Committee 1st listed author Jantina P Kortleve Journal Bone Marrow Transplant.